Presentation: Perivascular Macrophages: Key Suppressors of Antitumour Treatments

Time: 7:05 pm
day: Agenda: From Idea to Commercialization: Advancing the Biomarker Development Journey

Details:

• Perivascular macrophages can limit the efficacy of various anti-cancer treatments
• MultiOmyx analysis was used to define phenotype and functions of these macrophages in human breast tumours
• The study highlighted marked changes in the perivascular niche during treatment

Speakers: